A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma.
Jennifer E GainsVeronica MorozMatthew D AldridgeSimon WanKeith WheatleyJennifer LaidlerConnie PeetJamshed B BomanjiMark N GazePublished in: European journal of nuclear medicine and molecular imaging (2020)
ISRCTN98918118; URL: https://www.isrctn.com/search?q=98918118.
Keyphrases
- pet ct
- acute lymphoblastic leukemia
- acute myeloid leukemia
- early stage
- young adults
- study protocol
- phase iii
- multiple myeloma
- diffuse large b cell lymphoma
- hodgkin lymphoma
- clinical trial
- locally advanced
- phase ii
- radiation therapy
- neuroendocrine tumors
- radiation induced
- randomized controlled trial
- open label
- rectal cancer
- double blind